Bulgarian drug maker Sopharma said on Monday that Moldova's competition regulator has allowed it to acquire Moldovan pharmaceutical company RAP Pharma International.
"Moldova's competition regulator has granted its approval to Sopharma to acquire 51% of RAP Pharma International's capital," Sopharma said in a bourse filing on the Bulgarian stock exchange.
According to data from the Moldovan commercial registry, RAP Pharma International is 80% owned by Molfarm SRL, as individual investor Victor Alergus holds the remainder.
This is the latest in a series of acquisitions which Sopharma undertook lately.
Earlier this month it filed for regulatory approval for the acquisition of a stake in Bulgaria's Doverie United Holding, in which it holds over 25%.
In November, Sopharma acquired 68% of local drug producer Veta Pharma.
Sopharma shares closed 2.96% higher on Monday at 3.480 levs ($1.88/1.77 euro) as 84 shares changed hands on the BSE, See News writes.